David Einhorn's position in Gain Therapeutics is currently worth $1.05M. That's 0.04% of their equity portfolio (34th largest holding). The investor owns 1.27% of the outstanding Gain Therapeutics stock. David Einhorn acquired their 588k shares between 2021 and 2023. So far they never sold any shares in the company. The investor's estimated purchase price is $7.33M, resulting in a loss of 86%.